JP2002504522A5 - - Google Patents

Download PDF

Info

Publication number
JP2002504522A5
JP2002504522A5 JP2000533145A JP2000533145A JP2002504522A5 JP 2002504522 A5 JP2002504522 A5 JP 2002504522A5 JP 2000533145 A JP2000533145 A JP 2000533145A JP 2000533145 A JP2000533145 A JP 2000533145A JP 2002504522 A5 JP2002504522 A5 JP 2002504522A5
Authority
JP
Japan
Prior art keywords
formulation
antigen
adjuvant
composition
area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000533145A
Other languages
English (en)
Japanese (ja)
Other versions
JP4875799B2 (ja
JP2002504522A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/004128 external-priority patent/WO1999043350A1/en
Publication of JP2002504522A publication Critical patent/JP2002504522A/ja
Publication of JP2002504522A5 publication Critical patent/JP2002504522A5/ja
Application granted granted Critical
Publication of JP4875799B2 publication Critical patent/JP4875799B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000533145A 1998-02-25 1999-02-25 Ａｄｐ−リボシル化外毒素により誘引される経皮免疫応答を促進するための皮膚浸透性エンハンサーおよびバリア崩壊剤の使用 Expired - Fee Related JP4875799B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7585698P 1998-02-25 1998-02-25
US7585098P 1998-02-25 1998-02-25
US60/075,850 1998-02-25
US60/075,856 1998-02-25
PCT/US1999/004128 WO1999043350A1 (en) 1998-02-25 1999-02-25 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011225680A Division JP2012041355A (ja) 1998-02-25 2011-10-13 Ａｄｐ−リボシル化外毒素により誘引される経皮免疫応答を促進するための皮膚浸透性エンハンサーおよびバリア崩壊剤の使用

Publications (3)

Publication Number Publication Date
JP2002504522A JP2002504522A (ja) 2002-02-12
JP2002504522A5 true JP2002504522A5 (enExample) 2006-04-20
JP4875799B2 JP4875799B2 (ja) 2012-02-15

Family

ID=26757358

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000533145A Expired - Fee Related JP4875799B2 (ja) 1998-02-25 1999-02-25 Ａｄｐ−リボシル化外毒素により誘引される経皮免疫応答を促進するための皮膚浸透性エンハンサーおよびバリア崩壊剤の使用
JP2011225680A Pending JP2012041355A (ja) 1998-02-25 2011-10-13 Ａｄｐ−リボシル化外毒素により誘引される経皮免疫応答を促進するための皮膚浸透性エンハンサーおよびバリア崩壊剤の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011225680A Pending JP2012041355A (ja) 1998-02-25 2011-10-13 Ａｄｐ−リボシル化外毒素により誘引される経皮免疫応答を促進するための皮膚浸透性エンハンサーおよびバリア崩壊剤の使用

Country Status (9)

Country Link
EP (2) EP1061951B1 (enExample)
JP (2) JP4875799B2 (enExample)
AT (2) ATE247979T1 (enExample)
AU (1) AU3311599A (enExample)
BR (1) BR9908278A (enExample)
CA (1) CA2321596C (enExample)
DE (2) DE69910743T2 (enExample)
ES (1) ES2289200T3 (enExample)
WO (1) WO1999043350A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8974774B2 (en) 2004-03-03 2015-03-10 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6797276B1 (en) 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP1486215A3 (en) * 1997-03-21 2006-04-12 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
ATE529130T1 (de) * 1999-04-08 2011-11-15 Intercell Usa Inc Trockenformulierung für transkutane immunisierung
US20030078499A1 (en) 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
US6835184B1 (en) 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
US6595947B1 (en) 2000-05-22 2003-07-22 Becton, Dickinson And Company Topical delivery of vaccines
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
WO2002064162A2 (en) * 2001-02-13 2002-08-22 Government Of The United States, As Represented By The Secretary Of The Army Vaccine for transcutaneous immunization
EP1381381A1 (en) * 2001-03-19 2004-01-21 Gregory M. Glenn Patch for transcutaneous immunization
EP2316482A1 (en) 2001-03-19 2011-05-04 Intercell USA, Inc. Transcutaneous immunostimulation
AU2002339121B2 (en) * 2001-05-23 2007-03-22 Duotol Ab Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
DE60213976T2 (de) 2001-06-08 2007-04-26 Becton Dickinson And Co. Vorrichtung zur manipulation von nadeln oder polierarray
CA2451816A1 (en) 2001-06-29 2003-01-09 Becton, Dickinson And Company Intradermal delivery of vaccines and gene therapeutic agents via microcannula
DE60236806D1 (de) 2001-08-13 2010-08-05 Univ Rochester Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln
AU2002365077A1 (en) * 2001-09-19 2003-06-30 Massachusetts Institute Of Technology Methods and products related to non-viral transfection
AU2003265226A1 (en) 2002-03-11 2003-12-19 Altea Therapeutics Corporation Transdermal drug delivery device, method and use
US9918665B2 (en) 2002-03-11 2018-03-20 Nitto Denko Corporation Transdermal porator and patch system and method for using same
BR0311443A (pt) 2002-05-06 2005-03-22 Becton Dickinson Co Método e dispositivo para controlar farmacocinética de droga
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
EP1545605B8 (en) * 2002-10-02 2010-05-26 Nordic Vaccine A/S Composition for vaccination
EP1590432A4 (en) 2003-01-15 2008-05-14 Res Inst For Genetic And Human DNA COMPOSITION AND ITS USE
US8016811B2 (en) 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
US20060002960A1 (en) * 2003-12-09 2006-01-05 Paul Zoeteweij GM1 binding deficient exotoxins for use as immunoadjuvants
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
SG160357A1 (en) 2005-03-03 2010-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
EP1928537B1 (en) 2005-09-02 2015-01-21 Intercell USA, Inc. Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs
JP5186678B2 (ja) * 2005-10-13 2013-04-17 財団法人ヒューマンサイエンス振興財団 経皮抗原投与のための抗原キット
JP2009511636A (ja) 2005-10-18 2009-03-19 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド アルファウイルスレプリコン粒子による粘膜免疫および全身免疫
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
WO2010013350A1 (ja) 2008-08-01 2010-02-04 Ａｓｐｉｏｎ株式会社 Ｓ／ｏ型経皮免疫剤
DE102011018499A1 (de) 2011-04-23 2012-10-25 Emc Microcollections Gmbh Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut
WO2014044690A1 (en) 2012-09-18 2014-03-27 Valneva Austria Gmbh Improved vaccines
JP6577795B2 (ja) * 2014-09-03 2019-09-18 日東電工株式会社 ビスホスホネート剤を含む細胞性免疫用ワクチン医薬組成物
KR20220147278A (ko) 2021-04-27 2022-11-03 (주)아모레퍼시픽 리포푸신 축적 억제 또는 리포푸신 제거용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
JPS6468327A (en) * 1987-09-08 1989-03-14 Teisan Seiyaku Kk Warming type insulin-containing plaster
GB9513371D0 (en) * 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US5679647A (en) * 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
JPH07304690A (ja) * 1994-05-13 1995-11-21 Advanced Sukin Res Kenkyusho:Kk 角質溶解剤、経皮吸収促進剤及び皮膚外用製剤
JP2701005B2 (ja) * 1994-09-07 1998-01-21 株式会社林原生物化学研究所 減感作剤
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
WO1996037256A1 (en) * 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical patch for enhancing the delivery of compounds through the skin
JPH09124468A (ja) * 1995-10-27 1997-05-13 Nippon Zoki Pharmaceut Co Ltd 薬剤内包外皮用貼付剤
RS50101B (sr) * 1996-02-24 2009-01-22 Boehringer Ingelheim International Gmbh., Farmaceutski preparati za imunomodulaciju
JPH1025243A (ja) * 1996-07-09 1998-01-27 Showa Denko Kk 鎮痛消炎外用貼付剤
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8974774B2 (en) 2004-03-03 2015-03-10 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport

Similar Documents

Publication Publication Date Title
JP2002504522A5 (enExample)
CA2321596A1 (en) Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
JP4932086B2 (ja) 経皮的免疫のための乾燥製剤
AU2002252378B2 (en) Transcutaneous immunostimulation
US20090136480A1 (en) Transcutaneous immunostimulation
US6797276B1 (en) Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
JP4584361B2 (ja) 経皮的免疫のアジュバント
AU2002252378A1 (en) Transcutaneous immunostimulation
JP5275047B2 (ja) 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
JP5876468B2 (ja) 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
JP2004525921A (ja) 経皮免疫用パッチ
EP1768742A2 (en) Delivery system for transdermal immunization
JP2010059201A (ja) 経皮的免疫のアジュバント
EP1971393A2 (en) Method and device for transdermal immunization
JP2002535293A (ja) 無針の経皮的粉末薬物送達を増強する方法
EP1356821B1 (en) Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response
Glenn et al. Transcutaneous immunization
US20040047872A1 (en) Indicators for monitoring the technique of transcutaneous immunization
WO2018185113A1 (en) Pharmaceutical preparation for dermal administration
EP1849477A1 (en) Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin
IL180509A (en) Skin Transmission Transmission System